From compliance to complexity: the impact of in vitro diagnostic regulation for clinical microbiology laboratories
Clinical Microbiology and Infection · 2026
DOI: 10.1016/j.cmi.2026.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2026. Verfasst von Sangeeta Gaja-Lachman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Laboratories, Clinical, Microbiological Techniques, Diagnostic Tests, Routine, Clinical Laboratory Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Erasmus MC.
Abstract (Originalsprache)
OBJECTIVES: The implementation of the European in vitro medical devices regulation (IVDR) poses significant challenges, yet its impact has not previously been quantified in clinical microbiology. The aim of this study was to quantify the number of tests in a large clinical microbiology laboratory that may be affected by IVDR. METHODS: The study was performed in a clinical microbiology laboratory of a large academic hospital in the Netherlands. We calculated proportion of CE-marked tests and laboratory-developed tests (LDTs), and we calculated the number of test results generated by these tests. RESULTS: We found that CE-IVD-labelled tests accounted for 55% (57/104) of the available tests in bacteriology but represented 82.8% (99 521/120 254) of all test results generated in this specialty. Among tests in mycology, 38% (6/16) were LDTs. Most LDTs were PCR assays targeting specific microorganisms, such as Bordetella spp. and Candida auris. In contrast, only 29% (7/24) of parasitology tests had a CE-IVD label, and these accounted for 38.3% (1612/4209) of all test results in this specialty. CONCLUSIONS: We showed the potential burden in complying with IVDR 2017/746 in a clinical microbiology laboratory and the need for LDTs in certain setting. The results of this study may initiate informed discussion on a balanced implementation of the IVDR, ensuring compliance while minimizing unnecessary burden for clinical microbiology laboratories and also manufacturers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: angga.yusuf@gmail.com.
Förderung
- Erasmus MC
Zitieren
APA
Gaja-Lachman, S., De Visser-Timmermans, M., Langerak, D., Jansma, A., & Yusuf, E. (2026). From compliance to complexity: the impact of in vitro diagnostic regulation for clinical microbiology laboratories. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.01.005
Vancouver
Gaja-Lachman S, De Visser-Timmermans M, Langerak D, Jansma A, Yusuf E. From compliance to complexity: the impact of in vitro diagnostic regulation for clinical microbiology laboratories. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2026.01.005
BibTeX
@article{GajaLachman2026,
author = {Gaja-Lachman, Sangeeta and De Visser-Timmermans, Mariëlle and Langerak, Diana and Jansma, Amber and Yusuf, Erlangga},
title = {From compliance to complexity: the impact of in vitro diagnostic regulation for clinical microbiology laboratories},
journal = {Clinical Microbiology and Infection},
year = {2026},
doi = {10.1016/j.cmi.2026.01.005}
}
EUVIMED